Novartis Investigative Site

Galdakano, Basque Country 48960

0 studies enrolling now · 2 studies all time

What they study most

Coronary Artery Disease (CAD), Coronary Atherosclerosis, Heart Failure With Reduced Ejection Fraction (HF-rEF)

Studies at this site

• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE
• Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients — Completed